pharmaphorum

JANUARY 20, 2022

The mission to treat people who suffer from allergic rhinitis has been given a boost as two pharma companies join forces. According to Allergy UK, allergic rhinitis affects 10%-15% of children and 26% of adults in the UK.

Allergies 72

Allergies Marketing Production Manufacturing 72

pharmaphorum

NOVEMBER 30, 2022

The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas. Facts that they gleaned included: Across Europe, only 52% of HCPs will accept a visit from a pharma company (i.e. Veeva is equally ‘super excited’.

Life Science 98

Life Science Pharma Companies Sales Marketing 98

The Pharma Data

NOVEMBER 11, 2020

Lung Tx”) announced today an exclusive license agreement of LTI-01 , a recombinant human single-chain urokinase plasminogen activator, currently under development by Lung Tx for loculated pleural effusions , for the territory of Japan. is an R&D-driven specialty pharma company with a focus on oncology. 12, 2020 11:00 UTC.

Licensing 40

Licensing Licensing Allergies Development 40